ASXL1 and chronic myelomonocytic leukemia: Among them, mutations in TET2, SRSF2, and ASXL1 tended to occurred in MD-CMML, whereas mutations in RAS signaling transduction pathway were more prevalent in MP-CMML [13, 14].